Irvine-based Allergan Inc., maker of wrinkle-fighting Botox and other drugs, is gaining more attention on Wall Street. At least one analyst even crafted a pun—intended or otherwise—to lay out a case ...

Allergan Inc., maker of the wrinkle smoother Botox, said fourth-quarter profit fell 2.4% on spending to promote new products including breast implants and a skin-filling gel. Allergan’s net income ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...

Allergan filed a lawsuit against Pfizer Aug. 2 that would require the company to cover damages associated with several lawsuits brought against Allergan that allege it improperly marketed and sold an ...

The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

Just a few weeks after paying a $600 million to fine settle criminal charges that Botox was illegally marketed to treat headaches, Allergan (AGN) has won FDA approval to promote the med for treating ...

Botox, used for smoothing out wrinkles, is the number one selling neurotoxin globally Allergan Aesthetics’ main product Botox received Food and Drug Administration approval for a new indication in ...

AbbVie’s Allergan Aesthetics unit earlier this year had its first-ever open casting call as it looked for a new Botox campaign that would comprise real people using its product as a cosmetic and boy, ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...

CHICAGO/WASHINGTON, Sept 1 (Reuters) - Allergan Inc has agreed to plead guilty and pay $600 million to resolve a federal probe of its marketing practices for the injectable wrinkle smoother Botox, the ...